Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6090173rdf:typepubmed:Citationlld:pubmed
pubmed-article:6090173lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:6090173lifeskim:mentionsumls-concept:C0806036lld:lifeskim
pubmed-article:6090173lifeskim:mentionsumls-concept:C0005064lld:lifeskim
pubmed-article:6090173lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:6090173pubmed:issue1-2lld:pubmed
pubmed-article:6090173pubmed:dateCreated1984-11-20lld:pubmed
pubmed-article:6090173pubmed:abstractTextMadin-Darby canine kidney (MDCK) cells express a high density of binding sites (Bmax = 0.67 pmol/10(6) cells) for [3H]RO 5-4864, a peripheral-type benzodiazepine (BZD) receptor ligand. Receptor affinity (Kd = 45 nM) in MDCK cells is 30-50 fold lower than in rat kidney, but its pharmacological specificity is identical to that of peripheral-type BZD receptors in the rat kidney (PK 11195 greater than RO 5-4864 greater than diazepam = flunitrazepam greater than clonazepam). The MDCK cell line should provide a useful model system for studying the role of peripheral type BZD receptors in renal function.lld:pubmed
pubmed-article:6090173pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:languageenglld:pubmed
pubmed-article:6090173pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:citationSubsetIMlld:pubmed
pubmed-article:6090173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6090173pubmed:statusMEDLINElld:pubmed
pubmed-article:6090173pubmed:monthAuglld:pubmed
pubmed-article:6090173pubmed:issn0014-2999lld:pubmed
pubmed-article:6090173pubmed:authorpubmed-author:FanestilD DDDlld:pubmed
pubmed-article:6090173pubmed:authorpubmed-author:BeaumontKKlld:pubmed
pubmed-article:6090173pubmed:authorpubmed-author:MoberlyJ BJBlld:pubmed
pubmed-article:6090173pubmed:issnTypePrintlld:pubmed
pubmed-article:6090173pubmed:day3lld:pubmed
pubmed-article:6090173pubmed:volume103lld:pubmed
pubmed-article:6090173pubmed:ownerNLMlld:pubmed
pubmed-article:6090173pubmed:authorsCompleteYlld:pubmed
pubmed-article:6090173pubmed:pagination185-8lld:pubmed
pubmed-article:6090173pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:meshHeadingpubmed-meshheading:6090173-...lld:pubmed
pubmed-article:6090173pubmed:year1984lld:pubmed
pubmed-article:6090173pubmed:articleTitlePeripheral-type benzodiazepine binding sites in a renal epithelial cell line (MDCK).lld:pubmed
pubmed-article:6090173pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6090173pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed